![Li Shaodong](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Li Shaodong
Directeur des opérations chez Kunming Biomedical International Ltd.
Provenance du réseau au premier degré de Li Shaodong
Entité | Type d'entité | Industrie | |
---|---|---|---|
Kunming Biomedical International Ltd.
![]() Kunming Biomedical International Ltd. BiotechnologyHealth Technology Kunming Biomedical International Ltd. specializes in non human primate disease models. The firm expertise in developing and running specialized primate animal models to test drug candidates and medical devices for its pharmacological effects and biocompatible repairs. It specializes in vivo pharmacology, clinical chemistry and bio analytics, drug metabolism and pharmacokinetics, non-GLP toxicology and safety pharmacology, and histology and pathology. The company was founded in 2006 and is headquartered in Kunming, China.
1
| Holding Company | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Li Shaodong via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
HD Biosciences Co., Ltd.
![]() HD Biosciences Co., Ltd. Medical/Nursing ServicesHealth Services HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China. | Medical/Nursing Services | Corporate Officer/Principal | |
Metabasis Therapeutics, Inc.
![]() Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Dalian Medical University | College/University | Doctorate Degree | |
The University of Sydney | College/University | Doctorate Degree |
Statistiques
Internationale
Chine | 3 |
Etats-Unis | 2 |
Australie | 2 |
Sectorielle
Consumer Services | 3 |
Health Services | 2 |
Health Technology | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Doctorate Degree | 2 |
Chief Executive Officer | 1 |
Relations les plus connectées
Insiders | |
---|---|
Bao Zhong Zhang | 5 |
- Bourse
- Insiders
- Li Shaodong
- Connexions Sociétés